HIL Applied Medical is an R&D-stage medical-technology startup, on an accelerated growth path. We are developing a new class of compact, high-performance cancer proton-therapy systems.
HIL applies a patented approach to particle acceleration and beam delivery, combining nano-technology with Nobel-Prize-winning ultra-high-intensity lasers and ultra-fast magnets. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility.
Thus HIL aims to enable, for the first time, a single-room add-on proton therapy solution that is truly cost-effective. Affordable single-room systems are key to widespread adoption of this important therapy, and an enabler of a $10BB market (US).
HIL Applied Medical is a privately-held company, backed by VCs and global strategic partners. We are headquartered in the High-Tech Park, Givat Ram, Jerusalem, Israel; and have a wholly-owned subsidiary in Reno, Nevada (United States).
HIL applies a patented approach to particle acceleration and beam delivery, combining nano-technology with Nobel-Prize-winning ultra-high-intensity lasers and ultra-fast magnets. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility.
Thus HIL aims to enable, for the first time, a single-room add-on proton therapy solution that is truly cost-effective. Affordable single-room systems are key to widespread adoption of this important therapy, and an enabler of a $10BB market (US).
HIL Applied Medical is a privately-held company, backed by VCs and global strategic partners. We are headquartered in the High-Tech Park, Givat Ram, Jerusalem, Israel; and have a wholly-owned subsidiary in Reno, Nevada (United States).
Location: Israel, Jerusalem District, Jerusalem
Employees: 11-50
Founded date: 2010
Mentions in press and media 2
| Date | Title | Description |
| 13.02.2020 | Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date | OurCrowd is arguably the leading investment crowdfunding platform in the world. Based in Israel but listing offerings from companies around the world, OurCrowd has seen approximately $1.4 billion in committed funding since inception. Of the... |
| 27.05.2016 | HIL Applied Medical Buys US-based Nanolabz to Develop Advanced Cancer Radiotherapy Systems | HIL Applied Medical Ltd., a Jerusalem, Israel-based medical technology startup, acquired Nanolabz Inc., a Reno, Nevada-based company focused on developing and fabricating smart targets for laser-based proton acceleration. The amount of the ... |